|Dr Jane Muir|
A major area of their research involves investigating the role of poorly absorbed short chain carbohydrates (called FODMAPs) on the genesis of symptoms in patients with of functional gut disorders such as irritable bowel syndrome (IBS). Dr Muir will be speaking at the forthcoming 30 Sept Translational Research symposium hosted by Central Clinical School. See detail below.
Over the last 10 years- their team has proved a strong evidence base for the use of the Low FODMAP diet to control gastrointestinal symptoms associated with IBS. Dr Muir has helped to establish the techniques to quantify the various FODMAP carbohydrates in foods. The team at Monash have assembled the largest FODMAP food composition tables which have been essential for research into studying the physiological effects of these sugars in the gastrointestinal tract.
Dr Muir leads the team that developed the ‘Monash University Low FODMAP diet apps’ (for smartphones) which have greatly assisted with the translation of this new diet therapy for controlling IBS symptoms around the world. Dr Muir is now Scientific Director of the ‘Monash FODMAP initiative’ that is currently engaged in commercialising the FODMAP research.
All welcome, see details:
- Time: 8.00 am registration for 9.00 am start. Drinks and canapes from 6-8 pm
- Venue: AMREP Lecture Theatre, adjacent to the BakerIDI Institute at 85 Commercial Road, Melbourne 3004, 200 metres east of the main Alfred Hospital entrance. See map.
- Cost: Free
- RSVP by Friday 25 September for catering purposes
- Enquiries: Catherine.Wong@monash.edu ph +61 3 9903 0640